Goldberg Andrew D.
SEC insider (Form 3/4/5 filer). CIK 0001827722. Director at Tarsus Pharmaceuticals, Inc. (TARS) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in IRVINE, CA.
Companies Goldberg Andrew D. has filed insider reports for
- Tarsus Pharmaceuticals, Inc. (TARS): Director
- ACHIEVE LIFE SCIENCES, INC. (ACHV): Director, Officer, CEO and President
Goldberg Andrew D.
CIK: 0001827722
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
3.8K shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
2.4K shares- - Jun 12, 2026TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect3K shares- - Apr 18, 2026ACHV
ACHIEVE LIFE SCIENCES, INC.
AwardDirectPerformance Restricted Stock Unit (PRSU)
11.7M shares- - Apr 18, 2026ACHV
ACHIEVE LIFE SCIENCES, INC.
AwardDirectRestricted Stock Unit (RSU)
1.8M shares- - Apr 18, 2026ACHV
ACHIEVE LIFE SCIENCES, INC.
AwardDirectStock Option (right to buy)
3.6M shares- - Jun 13, 2025TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect3.4K shares- - Jun 12, 2025TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
3K shares- - Jun 12, 2025TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
4.5K shares- - Mar 7, 2025TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect7K shares at avg. $12.89$90K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 3,837 | - | - | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 2,417 | - | - | Direct |
| Jun 12, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 2,954 | - | $0 | Direct |
| Apr 18, 2026 |  ACHV ACHIEVE LIFE SCIENCES, INC. | Award Performance Restricted Stock Unit (PRSU) | 11,706,270 | - | - | Direct |
| Apr 18, 2026 | ACHV ACHIEVE LIFE SCIENCES, INC. | Award Restricted Stock Unit (RSU) | 1,800,965 | - | - | Direct |
| Apr 18, 2026 | ACHV ACHIEVE LIFE SCIENCES, INC. | Award Stock Option (right to buy) | 3,601,929 | - | - | Direct |
| Jun 13, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 3,350 | - | - | Direct |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 2,954 | - | - | Direct |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 4,540 | - | - | Direct |
| Mar 7, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 7,000 | $12.89 | $90,230 | Direct |
1-10 of 10 transactions